Trial Profile
Phase II Study to Evaluate the Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary) ; Dobutamine; Dopamine; Epinephrine; Milrinone
- Indications Acute heart failure
- Focus Therapeutic Use
- Acronyms LEVOPED1
- 03 Mar 2011 New trial record